top of page
  • lzeefe

Breaking News...Alzheimer's Drug That Showed Cognitive Decline Gets FDA Approval

Published 1/6/23 Washington Post.

"The Food and Drug Administration approved an Alzheimer’s drug that slowed cognitive decline in a major study, offering patients desperately needed hope — even as doctors sharply debated the safety of the drug and whether it provides a significant benefit. The FDA said the drug, called lecanemab, is for patients with mild cognitive impairment or early dementia because of Alzheimer’s. The accelerated approval was based on a mid-stage trial that showed the treatment effectively removed a sticky protein called amyloid beta — considered a hallmark of the illness — from the brain.

A larger trial, conducted more recently, found the drug, which will be sold under the brand name Leqembi, slowed the progression of Alzheimer’s disease by 27 percent."

10 views1 comment

Recent Posts

See All
bottom of page